The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
about
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recoveryHypoxia: an alarm signal during intestinal inflammationInflammatory bowel diseaseIn vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissueSulfated-polysaccharide fraction extracted from red algae Gracilaria birdiae ameliorates trinitrobenzenesulfonic acid-induced colitis in rats.Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease.Angiopoietin-2 in experimental colitisDaikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model.The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course.Role of the endothelium in inflammatory bowel diseases.Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.Adenosine prevents TNFα-induced decrease in endothelial mitochondrial mass via activation of eNOS-PGC-1α regulatory axis.Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitisImpairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome.Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.VEGF₁₆₄ isoform specific regulation of T-cell-dependent experimental colitis in mice.The inflammatory tissue microenvironment in IBD.Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: a review.New frontiers of MRI in Crohn's disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI).Epidemiology and risk factors for IBD.The Gastrointestinal Circulation: Physiology and Pathophysiology.Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.The extracellular matrix in IBD: a dynamic mediator of inflammation.Effects of Glutamine and Omega-3 Fatty Acids on Erythrocyte Deformability and Oxidative Damage in Rat Model of Enterocolitis.Altered chemokine signalling in endothelial progenitor cells from acute ulcerative colitis patients.Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice.Presynaptic inhibition of neural vasodilator pathways to submucosal arterioles by release of purines from sympathetic nerves.Impact of current smoking on the clinical course of microscopic colitis.A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium.Protective vascular effects of quercitrin in acute TNBS-colitis in rats: the role of nitric oxide.A role for interleukin 17A in IBD-related neuroplasticity.Development of a synthetic receptor protein for sensing inflammatory mediators interferon-γ and tumor necrosis factor-α.Anti-Inflammatory Effects of an Extract of Polygonum hydropiper Stalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway.
P2860
Q24620924-02CA0847-319D-45DE-B9D5-02C1FFBD175FQ27691319-DBE4DEEB-6562-47D7-97C9-C65A0A8EDAADQ29616286-3F956584-F633-4E01-A5DC-3EAE15FF755DQ30481061-931A5470-0F25-41AD-B2EA-AF67352755E2Q31151985-1E34D3D0-A8D5-4EF6-8AF7-9F446159F24BQ33842003-AAA42B5F-93F2-4490-83B2-479A94848AE9Q33897226-9B504F0D-BA83-4B29-A180-EC5AAEDEFD9FQ33978418-FB176601-BEEC-4A56-9ED8-8A59C0586E19Q34526079-146AB272-4EEC-423C-B362-35DEC09AB453Q34579746-3073AD27-ABE4-4F7F-8F69-8D7B71AF8A25Q34977591-B75E1A48-9CF2-4371-BD28-F7FA8470B01AQ35184659-8355284C-7E7E-421B-A9CB-E83F4E5596A5Q35211056-292B998D-9AE5-4A15-B991-488431D287E9Q35965047-8F863FA6-5598-4323-A762-22999EF06BA5Q36027964-4EBF96EA-98DE-463D-A0E4-CD906B14A928Q36702612-579A1CBC-BCED-45AD-AFF4-BB5783A9D1ECQ37110369-F9D265CB-48CA-4865-9F3B-89B11FB2943EQ37155166-58D2A9FB-2FEA-4B75-984A-745BE8C23A7AQ37421164-023D5C0D-CE0D-4C34-BDC9-F9D2081DFDF7Q37899837-09664061-41C6-402C-969D-7DCF66A06AFAQ38022456-5B46B4A1-F8AB-465F-94D4-8D0C2D4AA9E0Q38366954-5AB00C2E-B236-4906-AA27-A47D9FEC140CQ38542463-39F061BE-2A19-406F-9436-B0BCE0A49E00Q38588839-92530B3A-7B66-49E5-B816-C6501A37E08BQ39341011-F62BE2DE-7CEB-4913-A6D8-B4B4CFFE6E1DQ41329607-B7E80718-612E-4B98-BAB2-C2A9A12BBB99Q42074610-7262505A-9278-4166-A451-F1FBD453146AQ42406987-C65B2FF8-E562-4138-AFC9-18E4FCC4324DQ43149048-3FE2C26B-8E5E-4DAB-89EE-4D8883D8A1FCQ43674068-B76FE59E-2809-4979-B43D-A841F0D8F605Q44567599-AE478237-27CF-492E-8F1E-E7C9B1A70E28Q48132314-2E6C2257-E0B7-47BC-A481-BF73A34B3BCBQ48353162-9DB9F046-B777-4BB2-AC15-B0C92472DEFDQ51720186-036D2B18-DBB4-4CBA-8E02-3486C6F18521Q55002814-E6DCD91A-1A6F-47D2-A7C9-7EE897731615
P2860
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@ast
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@en
type
label
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@ast
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@en
prefLabel
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@ast
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
@en
P2093
David G Binion
Jan Heidemann
Ossama A Hatoum
P2860
P356
10.1196/ANNALS.1326.003
P407
P577
2006-08-01T00:00:00Z